Back to search
FDAFDA · Food and drugs·Recall number Z-0128-2017

CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen

Published October 26, 2016 · Recall initiated: September 21, 2016

Summary

FDA records medical device Class II recall Z-0128-2017, published October 26, 2016 and initiated September 21, 2016. Recalling firm: Becton, Dickinson and Company, BD Biosciences; Status: Terminated; Reported quantity: 14 units; Lot: Lot number: 5348570; Expiration Date: 31 July 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton, Dickinson and Company, BD Biosciences
Distributor
Nationwide Distribution to CA, MN, OH and TX.
Lot
Lot number: 5348570; Expiration Date: 31 July 2017
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen recalled?

Yes. FDA published recall Z-0128-2017 on October 26, 2016. Reported hazard: CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity

What should I do if I have this product?

Voluntary: Firm initiated · Letter